Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
155.55
-2.51 (-1.59%)
At close: Mar 28, 2025, 4:00 PM
154.36
-1.19 (-0.77%)
Pre-market: Mar 31, 2025, 7:53 AM EDT
CRL Employees
Charles River Laboratories International had 20,100 employees as of December 31, 2024. The number of employees decreased by 1,700 or -7.80% compared to the previous year.
Employees
20,100
Change (1Y)
-1,700
Growth (1Y)
-7.80%
Revenue / Employee
$201,492
Profits / Employee
$512
Market Cap
7.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20,100 | -1,700 | -7.80% |
Dec 31, 2023 | 21,800 | 400 | 1.87% |
Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
Dec 30, 2017 | 11,800 | 800 | 7.27% |
Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
Dec 26, 2015 | 8,600 | 700 | 8.86% |
Dec 27, 2014 | 7,900 | 200 | 2.60% |
Dec 28, 2013 | 7,700 | 500 | 6.94% |
Dec 29, 2012 | 7,200 | 100 | 1.41% |
Dec 31, 2011 | 7,100 | -400 | -5.33% |
Dec 25, 2010 | 7,500 | -500 | -6.25% |
Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
Dec 27, 2008 | 9,000 | 500 | 5.88% |
Dec 29, 2007 | 8,500 | 500 | 6.25% |
Dec 30, 2006 | 8,000 | -400 | -4.76% |
Dec 31, 2005 | 8,400 | 400 | 5.00% |
Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
Dec 27, 2003 | 4,500 | -500 | -10.00% |
Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
Dec 29, 2001 | 4,000 | 500 | 14.29% |
Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CRL News
- 6 days ago - Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform - Business Wire
- 20 days ago - Charles River Laboratories to Present at Barclays Global Healthcare Conference - Business Wire
- 27 days ago - FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility - Business Wire
- 4 weeks ago - Charles River Announces Agreement with Singapore General Hospital - Business Wire
- 5 weeks ago - Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance - Benzinga
- 5 weeks ago - Charles River Laboratories International, Inc. (CRL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Charles River beats quarterly estimates on stable demand for drug development services - Reuters
- 5 weeks ago - Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance - Business Wire